Abstract
Several forms of the polypeptide atrial natriuretic factor (ANF) have been isolated recently from rat and human atria and identified1–3; they are probably associated with the secretory granules of atrial tissue4. The potent ability of ANFs to increase urine sodium content is mediated by their direct action on the kidney5,6. We report here the high intrinsic activity of a synthetic replicate of one form of this molecule, ANF(8-33) (ref. 7), to inhibit directly basal aldosterone secretion and its ability to antagonize the stimulatory effects of adrenocorticotropin (ACTH) and angiotensin II (AN-II) on the secretion of aldosterone by rat adrenoglomerulosa cells in vitro. Our results suggest that ANF is of clinical importance in the management of aldosterone-dependent hypertension by modifying the adrenocortical response to endogenous ACTH and AN-II.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Flynn, T. G., deBold, M. L. & deBold, A. J. Biochem. biophys. Res. Commun. 117, 859–865 (1983).
Currie, M. G. et al. Science 223, 67–69 (1984).
Kangawa, K. & Matsuo, H. Biochem. biophys. Res. Comm. 118, 131–139 (1984).
Jamieson, J. D. & Palade, G. E. J. Cell Biol. 23, 151–171 (1964).
Sonneberg, H., Cupples, W. A., deBold, A. J. & Veress, A. T. Can. J. Physiol. Pharmac. 60, 1149–1152 (1982).
Keeler, R. Can. J. Physiol. Pharmac. 60, 1078–1082 (1982).
Thibault, G. et al. FEBS Lett. 167, 352–356 (1984).
Tait, S. A. S. et al. Biochemistry 5, 775–787 (1974).
Edwards et al. Clin. Endocr. 13, 45–50 (1980).
Douglas, J., Aguilera, G., Kondo, T. & Catt, K. J. Endocrinology 102, 685–696 (1978).
Hornsby, P. J. & Gill, G. N. Endocrinology 102, 926–936 (1978).
Aguilera, G., Harwood, J. P. & Catt, K. J. Nature 292, 262–263 (1981).
Boscaro, M., Scaroni, V., Edwards, C. R. W. & Mantero, F. J. endocr. Invest. 5, 173–177 (1982).
Szalay, K. S. & Stark, E. Life Sci. 29, 1355–1361 (1981).
Racz, K. et al. J. clin. Endocr. Metab. 54, 656–660 (1982).
Nicholls, M. G. et al. Endocrinology 102, 485–493 (1978).
Cowley, A. W. & McCaa, R. E. Circulation Res. 39, 788–797 (1976).
New, M. I. & Levine, L. S. Endocrine Rev. 1, 421–430 (1980).
Zipser, R. D. et al. J. clin. Endocr. Metab. 53, 867–873 (1981).
Chartier, L., Schiffrin, E., Thibault, G. & Garcia, R. Endocrinology (in the press).
DeLean, A. et al. Endocrinology (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kudo, T., Baird, A. Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor. Nature 312, 756–757 (1984). https://doi.org/10.1038/312756a0
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/312756a0
This article is cited by
-
Protection of kidney function and tissue integrity by pharmacologic use of natriuretic peptides and neprilysin inhibitors
Pflügers Archiv - European Journal of Physiology (2021)
-
BK channels and a new form of hypertension
Kidney International (2010)
-
Membrane guanylate cyclase is a beautiful signal transduction machine: overview
Molecular and Cellular Biochemistry (2010)
-
Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome
Molecular and Cellular Biochemistry (2010)
-
Intracerebroventricular administration of atrial natriuretic peptide prevents increase of plasma ADH, aldosterone and corticosterone levels in restrained conscious dehydrated rabbits
Journal of Endocrinological Investigation (2004)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
